DNX BIOTHERAPEUTICS
DNX BIOTHERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care
Address:
Princeton, New Jersey, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
0
Investors List
EvoNexus
EvoNexus investment in Non Equity Assistance - DNX Biotherapeutics
More informations about "DNX Biotherapeutics"
DNX Biotherapeutics - Crunchbase Company Profile & Funding
DNX Biotherapeutics is a Biotechnology company. Where is DNX Biotherapeutics's headquarters? DNX Biotherapeutics is located in Princeton, New Jersey, United States. Who …See details»
DNX Biotherapeutics - Funding, Financials, Valuation & Investors
May 1, 2016 Organization. DNX Biotherapeutics . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. Highlights. Funding Rounds 1. …See details»
DNX Biopharmaceuticals - Crunchbase Company Profile & Funding
DNX is a biopharmaceutical company developing long-acting therapeutic proteins for the treatment of patients with life-long diseases.See details»
DNX Biotherapeutics: Drug pipelines, Patents, Clinical trials - Synapse
Aug 9, 2023 Explore DNX Biotherapeutics with its drug pipeline, therapeutic area, technology platform, 3 literature. Data. Feature. Plans. Sign Up for Free. Request Demo. Sign Up for …See details»
DNX Biopharmaceuticals, Inc. - Drug pipelines, Patents, Clinical …
Explore DNX Biopharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 14 news, and 1 literature, Disease Domain:Endocrinology and Metabolic Disease, …See details»
DNX Biopharmaceuticals Company Profile | Management and
DNX is a biopharmaceutical company developing long-acting therapeutic proteins for the treatment of patients with life-long diseases. Founded in 2014 and headquartered in San …See details»
DNX Biopharmaceuticals, Inc. - VentureRadar
DNX is a biopharmaceutical company developing long-acting therapeutic proteins for the treatment of patients with life-long diseases. DNX is pursuing the development of new …See details»
DNX BIOTHERAPEUTICS INC innovation strategy - GoodIP
DNX BIOTHERAPEUTICS INC has a total of 14 patent applications. Its first patent ever was published in 1993. It filed its patents most often in United States, Australia and Canada. Its …See details»
DNX Biopharmaceuticals - PitchBook
DNX Biopharmaceuticals General Information Description. Operator of a biopharmaceutical company intended to develop long-acting therapeutic proteins for the treatment of patients with …See details»
DNX Biopharmaceuticals - LinkedIn
DNX Biopharmaceuticals | 45 followers on LinkedIn. DNX is a biopharmaceutical company developing long-acting therapeutic proteins for the treatment of patients with life-long …See details»
DNX Biopharmaceuticals - Overview, News & Similar companies
Feb 17, 2020 DNX is a resident of Johnson and Johnson Innovation - JLABS, Shanghai, a JLABS QuickFire Challenge (QFC) winner and has just closed a deal with the Lung Cancer …See details»
DNX Biopharmaceuticals - Products, Competitors, Financials, …
DNX Biopharmaceuticals is a biopharmaceutical company developing therapeutic proteins for the treatment of patients with life-long diseases. Use the CB Insights Platform to explore DNX …See details»
DNX Biotherapeutics - Crunchbase
DNX Biotherapeutics is a Biotechnology company. Start Free Trial . Chrome ExtensionSee details»
DNX Biopharmaceuticals Inc. - BioCentury Company Profiles - BCIQ
Jun 27, 2019 DNX Biopharmaceuticals Inc. - BioCentury Company Profiles for the biopharma industrySee details»
DNX Biopharmaceuticals Announces Collaboration with Lung …
Feb 19, 2020 DNX Biopharmaceuticals, a biopharmaceutical company developing long-acting therapeutic proteins for the treatment of patients with life-long diseases and a resident of …See details»
DNX Biopharmaceuticals Announces Collaboration With Lung …
Feb 18, 2020 About DNX Biopharmaceuticals, Inc. Founded in 2014 and headquartered in San Diego, California, USA, DNX is a biopharmaceutical company developing non-immunogenic, …See details»
DNX Biopharmaceuticals, Inc. - VentureRadar
DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and production in Denmark and …See details»
Early-Stage Biotech Value Creation: The Roles of Equity and
Aug 15, 2018 Thus, Millennium established a subsidiary, Millennium BioTherapeutics, [24] which had the rights to exploit genes encoding proteins elaborated on the cell surface to develop …See details»
DNX Biopharmaceuticals Announces Collaboration With Lung …
Feb 18, 2020 San Diego, California–(Newsfile Corp. – February 18, 2020) – DNX Biopharmaceuticals, a biopharmaceutical company developing long-acting therapeutic …See details»
DNX Biopharmaceuticals Announces Collaboration With Lung
Feb 18, 2020 DNX Biopharmaceuticals Announces Collaboration With Lung Cancer Initiative at Johnson & Johnson February 18, 2020 10:00 AM EST | Source: DNX Biopharmaceuticals San …See details»